Sale!

MSX2 Gene Craniosynostosis Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MSX2 gene craniosynostosis type 2 genetic test is a specialized diagnostic tool designed to identify mutations in the MSX2 gene, which are associated with the development of craniosynostosis type 2, a rare genetic disorder. This condition is characterized by the premature fusion of certain skull bones, leading to abnormal head shape and potentially causing pressure on the brain with developmental issues. The test is crucial for early detection, allowing for timely intervention and management of the condition to mitigate complications.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic mutations in the MSX2 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately diagnose this condition. By identifying the presence of these genetic mutations, healthcare providers can better understand the condition’s progression, tailor treatments to the individual’s needs, and offer genetic counseling to affected families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MSX2 Gene Craniosynostosis type 2 Genetic Test

Components: MSX2 Gene Craniosynostosis type 2 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test gene MSX2

Test Details

The MSX2 gene is associated with a condition called craniosynostosis type 2, which is a rare genetic disorder characterized by the premature fusion of the skull bones. This condition can lead to abnormal skull shape, facial features, and potential neurological complications.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify variations or mutations in specific genes associated with genetic disorders. In the case of craniosynostosis type 2, NGS can be used to identify mutations or variations in the MSX2 gene. NGS testing involves sequencing the entire coding region of the gene to identify any potential changes or mutations.

This can help in diagnosing individuals with craniosynostosis type 2 and can also be used for carrier testing in families with a history of the condition. By identifying the specific genetic mutation in the MSX2 gene, NGS testing can provide valuable information for genetic counseling, family planning, and potential treatment options for affected individuals.

Test Name MSX2 Gene Craniosynostosis type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test gene MSX2
Test Details

The MSX2 gene is associated with a condition called craniosynostosis type 2, which is a rare genetic disorder characterized by the premature fusion of the skull bones. This condition can lead to abnormal skull shape, facial features, and potential neurological complications.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify variations or mutations in specific genes associated with genetic disorders. In the case of craniosynostosis type 2, NGS can be used to identify mutations or variations in the MSX2 gene.

NGS testing involves sequencing the entire coding region of the gene to identify any potential changes or mutations. This can help in diagnosing individuals with craniosynostosis type 2 and can also be used for carrier testing in families with a history of the condition.

By identifying the specific genetic mutation in the MSX2 gene, NGS testing can provide valuable information for genetic counseling, family planning, and potential treatment options for affected individuals.